IP Library Granted Patent US 12,419,790
Granted Patent B2
US 12,419,790 · App. 17/921,597 · Granted Sep 23, 2025

Apparatuses and methods for negative pressure wound therapy

Inventors: Victoria Beadle (Hull, GB); Varuni Rachindra Brownhill (Swanland, GB); Brian Gilchrist (Loosley Row, GB); Danielle Susan Johnson (Hull, GB); Luke Michael Parry (Goole, GB); Hannah Bailey Weedon (Hull, GB)
Assignee: T.J.Smith and Nephew, Limited
A61F13/05A61F13/0203A61M1/90A61F2013/00089
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,419,790
App. No.
17/921,597
Granted
Sep 23, 2025
Kind
B2
Abstract

Disclosed embodiments related to a wound dressing for treating circumferential wounds for use in a negative pressure wound therapy (NPWT). The wound dressing can include a cover layer, a plurality of spacer sections, and a wound contact layer. The wound dressing can further include a port for connection to a source of negative pressure and a connector for fluidically connecting each of the plurality of sections with the port.

Claims (31)

1. A negative pressure wound therapy dressing configured for treating a circumferential surface, comprising:

a cover layer;

a wound contact layer;

a plurality of spacer sections positioned between the cover layer and the wound contact layer, each spacer section separated from another spacer section by a gap region therebetween, wherein the cover layer and the wound contact layer are configured to be sealed together at individual gap regions;

a port configured to be connected to a source of negative pressure;

a connector configured to fluidically connect each of the plurality of spacer sections with the port; and

a trim line along at least one gap region and across the connector.

2. The negative pressure wound therapy dressing of claim 1 , wherein the connector comprises a plurality of inlets connected to the plurality of spacer sections and an outlet connected to the port.

3. The negative pressure wound therapy dressing of claim 1 , wherein the connector comprises a spacer fabric material.

4. The negative pressure wound therapy dressing of claim 1 , wherein each of the spacer sections comprise a distal end, a proximal end, a length extending from the distal end to the proximal end, and a width perpendicular to the length.

5. The negative pressure wound therapy dressing of claim 4 , wherein the connector is connected to the proximal end of a spacer section.

6. The negative pressure wound therapy dressing of claim 4 , wherein the length is greater than the width.

7. The negative pressure wound therapy dressing of claim 1 , wherein each of the spacer sections is fluidically isolated from the other spacer sections except for at the connector.

8. The negative pressure wound therapy dressing of claim 1 , further comprising one or more tubes connecting the plurality of spacer sections and the connector.

9. The negative pressure wound therapy dressing of claim 1 , wherein the cover layer comprises one or more openings and the port is positioned above the one or more openings.

10. The negative pressure wound therapy dressing of claim 1 , wherein the cover layer comprises an extension portion at one end of the cover layer, wherein the extension portion can be overlapped over another regions of the cover layer when the dressing is applied to a wound.

11. A method of treating a circumferential wound comprising:

providing a wound dressing comprising:

a cover layer,

a wound contact layer,

a plurality of spacer sections positioned between the cover layer and the wound contact layer, each spacer section separated from another spacer section by a gap region therebetween, wherein the cover layer and the wound contact layer are configured to be sealed together at individual gap regions,

a port configured to be connected to a source of negative pressure, and

a connector configured to fluidically connect each of the plurality of sections with the port;

applying the wound dressing around the circumferential wound; and

trimming a portion of the wound dressing along a trim line along at least one gap region and across the connector.

12. The method of claim 11 , wherein applying the wound dressing around the circumferential wound comprises wrapping the wound dressing around the circumferential wound such that an end of the cover layer overlaps with another end of the cover layer.

13. The method of claim 12 , wherein the cover layer comprises an extension portion at one end of the cover layer, wherein the extension portion can be overlapped over another regions of the cover layer.

14. The method of claim 11 , further comprising applying negative pressure to the circumferential wound through the port.

15. The method of claim 11 , wherein the connector comprises a plurality of inlets connected to the plurality of spacer sections and an outlet connected to the port.

16. The method of claim 11 , wherein the connector comprises a spacer fabric material.

17. The method of claim 11 , wherein each of the spacer sections comprise a distal end, a proximal end, a length extending from the distal end to the proximal end, and a width perpendicular to the length, wherein applying the wound dressing around the circumferential wound comprises positioning the length of the spacer sections along the length of the circumferential wound.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 21, 2024
From: BEADLE, VICTORIA; BROWNHILL, VARUNI RACHINDRA; GILCHRIST, BRIAN; JOHNSON, DANIELLE SUSAN; PARRY, LUKE MICHAEL; WEEDON, HANNAH BAILEY
To: T.J.SMITH AND NEPHEW,LIMITED
Reel/Frame 068957/0148 →
Priority Claims (1)
GB 2006305 · Apr 29, 2020 · national
Continuity (1)
Related Publication 20230165724A1 · Jun 1, 2023
References Cited (126)
US 3903882A · Augurt · 1975 [cited by applicant]
US 4181127A · Linsky et al. · 1980 [cited by applicant]
US 5308313A · Karami et al. · 1994 [cited by applicant]
US 5540922A · Fabo · 1996 [cited by applicant]
US 5549584A · Gross · 1996 [cited by applicant]
US 5636643A · Argenta et al. · 1997 [cited by applicant]
US 6653520B1 · Mouton · 2003 [cited by applicant]
US 7338482B2 · Lockwood et al. · 2008 [cited by applicant]
US 7569742B2 · Haggstrom et al. · 2009 [cited by applicant]
US 7708724B2 · Weston · 2010 [cited by applicant]
US 7723560B2 · Lockwood et al. · 2010 [cited by applicant]
US 7779625B2 · Joshi et al. · 2010 [cited by applicant]
US 7909805B2 · Weston · 2011 [cited by applicant]
US 7959624B2 · Riesinger · 2011 [cited by applicant]
US 7985209B2 · Villanueva et al. · 2011 [cited by applicant]
US 8062272B2 · Weston · 2011 [cited by applicant]
US 8172816B2 · Kazala, Jr. et al. · 2012 [cited by applicant]
US 8513481B2 · Gergely et al. · 2013 [cited by applicant]
US 8679080B2 · Kazala, Jr. et al. · 2014 [cited by applicant]
US 8708998B2 · Weston et al. · 2014 [cited by applicant]
US 8801685B2 · Armstrong et al. · 2014 [cited by applicant]
US 8808274B2 · Hartwell · 2014 [cited by applicant]
US 10080689B2 · Hall et al. · 2018 [cited by applicant]
US 10548777B2 · Locke et al. · 2020 [cited by applicant]
US 10940046B2 · Locke · 2021 [cited by applicant]
US 11007084B2 · Robinson et al. · 2021 [cited by applicant]
US 11224543B2 · Locke · 2022 [cited by applicant]
US 11614170B2 · Tumey et al. · 2023 [cited by applicant]
US 11752252B2 · Randolph et al. · 2023 [cited by applicant]
US 12178954B2 · Robinson et al. · 2024 [cited by applicant]
US 20030045825A1 · Etheredge, III · 2003 [cited by applicant]
US 20030153860A1 · Nielsen et al. · 2003 [cited by applicant]
US 20030212359A1 · Butler · 2003 [cited by applicant]
US 20040127836A1 · Sigurjonsson et al. · 2004 [cited by applicant]
US 20040138602A1 · Rossen · 2004 [cited by applicant]
US 20040200094A1 · Baychar · 2004 [cited by applicant]
US 20060241542A1 · Gudnason et al. · 2006 [cited by applicant]
US 20060282028A1 · Howard et al. · 2006 [cited by applicant]
US 20080167593A1 · Fleischmann · 2008 [cited by applicant]
US 20090234307A1 · Vitaris · 2009 [cited by applicant]
US 20090299251A1 · Buan · 2009 [cited by applicant]
US 20100010462A1 · Kurata · 2010 [cited by applicant]
US 20110004172A1 · Eckstein et al. · 2011 [cited by applicant]
US 20110112492A1 · Bharti et al. · 2011 [cited by applicant]
US 20110224631A1 · Simmons et al. · 2011 [cited by applicant]
US 20120238932A1 · Atteia et al. · 2012 [cited by applicant]
US 20120253302A1 · Corley · 2012 [cited by applicant]
US 20150190286A1 · Allen et al. · 2015 [cited by applicant]
US 20160135998A1 · Riesinger · 2016 [cited by applicant]
US 20170291020A1 · Tolia et al. · 2017 [cited by applicant]
US 20180021178A1 · Locke et al. · 2018 [cited by applicant]
US 20180228945A1 · Guirguis et al. · 2018 [cited by applicant]
US 20180333522A1 · Pratt · 2018 [cited by examiner]
US 20180353336A1 · Locke et al. · 2018 [cited by applicant]
US 20180353338A1 · Locke et al. · 2018 [cited by applicant]
US 20180353662A1 · Locke et al. · 2018 [cited by applicant]
US 20180353663A1 · Locke et al. · 2018 [cited by applicant]
US 20180369462A1 · Anderson et al. · 2018 [cited by applicant]
US 20190015258A1 · Gowans et al. · 2019 [cited by applicant]
US 20190029886A1 · Lin · 2019 [cited by applicant]
US 20190110932A1 · Mumby et al. · 2019 [cited by applicant]
US 20190117861A1 · Locke et al. · 2019 [cited by applicant]
US 20190192350A1 · Gowans et al. · 2019 [cited by applicant]
US 20190307935A1 · Simmons et al. · 2019 [cited by applicant]
US 20200038283A1 · Hall · 2020 [cited by examiner]
US 20200069477A1 · Holm et al. · 2020 [cited by applicant]
US 20200093646A1 · Locke et al. · 2020 [cited by applicant]
US 20200107965A1 · Greener · 2020 [cited by applicant]
US 20200170841A1 · Waite et al. · 2020 [cited by applicant]
US 20200214897A1 · Long et al. · 2020 [cited by applicant]
US 20200246190A1 · Luckemeyer et al. · 2020 [cited by applicant]
US 20200268561A1 · Locke et al. · 2020 [cited by applicant]
US 20200297905A1 · Gellman et al. · 2020 [cited by applicant]
US 20200306092A1 · Rehbein et al. · 2020 [cited by applicant]
US 20200306430A1 · Rehbein et al. · 2020 [cited by applicant]
US 20210106737A1 · Obst et al. · 2021 [cited by applicant]
US 20210128340A1 · Jahanian et al. · 2021 [cited by applicant]
US 20210161725A1 · Edwards et al. · 2021 [cited by applicant]
US 20210177661A1 · Poole et al. · 2021 [cited by applicant]
US 20220117797A1 · Adie et al. · 2022 [cited by applicant]
US 20220152287A1 · Loske · 2022 [cited by applicant]
US 20220184294A1 · Locke et al. · 2022 [cited by applicant]
US 20230201445A1 · Earl et al. · 2023 [cited by applicant]
US 20240074910A1 · Askem et al. · 2024 [cited by applicant]
US 20240074911A1 · Madriz et al. · 2024 [cited by applicant]
US 20240390191A1 · Jeyakumaran et al. · 2024 [cited by applicant]
DE 102008020553A1 · 2008 [cited by applicant]
EP 0507459A1 · 1992 [cited by applicant]
EP 3023083A1 · 2016 [cited by applicant]
EP 3365039B1 · 2020 [cited by applicant]
GB 2527617A · 2015 [cited by applicant]
JP S61288860A · 1986 [cited by applicant]
JP 2004521665A · 2004 [cited by applicant]
JP 2012024124A · 2012 [cited by applicant]
JP 2014065183A · 2014 [cited by applicant]
WO WO2007082538A1 · 2007 [cited by applicant]
WO WO2009066106A1 · 2009 [cited by applicant]
WO WO2011063818A1 · 2011 [cited by applicant]
WO WO2013175306A2 · 2013 [cited by applicant]
WO WO2014003957A1 · 2014 [cited by applicant]
WO WO2014140606A1 · 2014 [cited by applicant]
WO WO2014140608A1 · 2014 [cited by applicant]
WO WO2015052219A1 · 2015 [cited by applicant]
WO WO2015193257A1 · 2015 [cited by applicant]
WO WO2016018706A1 · 2016 [cited by applicant]
WO WO2016174048A1 · 2016 [cited by applicant]
WO WO2017186771A1 · 2017 [cited by applicant]
WO WO2018125739A1 · 2018 [cited by applicant]
WO WO2018226630A1 · 2018 [cited by applicant]
WO WO2018226667A1 · 2018 [cited by applicant]
WO WO2019027731A1 · 2019 [cited by applicant]
WO WO2019067264A1 · 2019 [cited by applicant]
WO WO2019083868A1 · 2019 [cited by applicant]
WO WO2019226900A1 · 2019 [cited by applicant]
WO WO2020005535A1 · 2020 [cited by applicant]
WO WO2020046935A1 · 2020 [cited by applicant]
WO WO2021001737A1 · 2021 [cited by applicant]
WO WO2021009712A1 · 2021 [cited by applicant]
WO WO2021014297A1 · 2021 [cited by applicant]
WO WO2021033051A1 · 2021 [cited by applicant]
WO WO2021033052A1 · 2021 [cited by applicant]
WO WO2021059124A1 · 2021 [cited by applicant]
WO WO2021116977A1 · 2021 [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/EP2021/061186, mailed on Aug. 24, 2021, 14 pages. [cited by applicant]
Smith & Nephew, “Allevyn: Technical Information Sheet,” Dec. 2013, 2 pages. [cited by applicant]
International Preliminary Report on Patentability for Application No. PCT/EP2021/061186, mailed on Nov. 10, 2022, 8 pages. [cited by applicant]